Defective Medical Devices
Defective medical devices can cause injury and harm to unknowing patients. Medical device users expect treatments to work effectively and safely without undue risk or harm. Independent institutions, such as the Food and Drug Administration (FDA), place medical devices through extensive testing before releasing them to the consumer market. If potential risks and side effects are found, they are documented thoroughly and the user of the medical device is informed of any potential detriment to their health.
Regardless of this testing, medical devices are sometimes found to be faulty under certain circumstances or to raise the overall chance of illness or injury. The Guidant Defibrillator is one example of a defective medical device. Once installed, some models of the defibrillator run the risk of causing serious injury to the patient at an unknown time. Dealing with the risks associated with a defective medical device can have life-altering consequences.
In the event a defective medical device causes injury or death, the manufacturers of the device may be held legally liable for marketing a dangerous product. Some legal actions associated with defective medical devices evolve into class action or mass tort suits, whereby those affected by the hazardous devices can make a personal injury claim for a predetermined amount of compensation.
If you or a loved one has suffered an injury, illness, or death due to a defective medical device, call VanDerGinst Law at 1-866-843-7367 or click here for a FREE online case evaluation. The initial consultation is free of charge. If we agree to handle your injury case, we will work on a contingency fee basis, which means we get paid for our services only if, and when, there is a money recovery for you. In many cases a lawsuit must be filed before an applicable expiration date, known as a statute of limitations. So please call right away to ensure that you do not waive your right to possible compensation.
Defective Medical Devices
Links on the Web
 FDA MedWatchFDA MedWatch Safety Alerts |
| Wed, 31 Dec 2008 20:01:00 EDT Innohep (tinzaparin sodium injection) [UPDATE] Dear Healthcare Professional letter issued re: increased risk of death in elderly patients with renal insufficiency Click here to read this Defective Medical Devices news article. |
| Wed, 24 Dec 2008 10:40:00 EDT Stryker Custom Cranial Implant Kits Class 1 recall because sterility cannot be assured. Click here to read this Defective Medical Devices news article. |
| Wed, 24 Dec 2008 10:40:00 EDT Hydromorphone HCl 2 mg Tablets Nationwide recall of a single lot due to potential for oversized tablets. Click here to read this Defective Medical Devices news article. |
| Mon, 22 Dec 2008 17:40:00 EDT Weight Loss Pills Products contain undeclared, active pharmaceutical ingredients that may put consumers' health at risk. Click here to read this Defective Medical Devices news article. |
| Fri, 19 Dec 2008 15:00:00 EDT Greenline-D MacIntosh No. 3 Laryngoscope Blades Class 1 recall due to potential for piece of blade to break off during procedure. Click here to read this Defective Medical Devices news article. |
| Fri, 19 Dec 2008 11:56:00 EDT October 2008 Safety Labeling Changes Summary of safety-related revisions to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, and ADVERSE REACTIONS sections of drug Prescribing Information, plus Patient Package Inserts and Medication Guides. Click here to read this Defective Medical Devices news article. |
| National Institutes of Health (NIH) News Releases News Releases from the National Institutes of Health (NIH) |
| Fri, 02 Jan 2009 09:45:00 EST Addressing Substance Abuse and Comorbidities among Military Personnel, Veterans, and Their Families: A Research Agenda There is growing concern that military personnel returning from Iraq and Afghanistan are experiencing a range of difficulties, including traumatic brain injury (TBI), post traumatic stress disorder (PTSD), depression, anxiety, and alcohol and drug abuse. Click here to read this Defective Medical Devices news article. |
| Fri, 02 Jan 2009 09:45:00 EST Inherited Factors Play an Important Role in Breast Cancer Progression According to New Study in Mice New research in mice and five independent collections of human breast tumors has enabled National Cancer Institute (NCI) scientists to confirm that genes for factors contributing to susceptibility for breast cancer metastasis can be inherited. Click here to read this Defective Medical Devices news article. |
| Fri, 02 Jan 2009 09:00:00 EST Scientists Identify New Congenital Neutropenia Syndrome and Causative Gene Mutation A team of scientists has discovered a new syndrome associated with severe congenital neutropenia (SCN), a rare disorder in which children lack sufficient infection-fighting white cells, and identified the genetic cause of the syndrome: mutations in the gene Glucose-6-phosphatase, catalytic subunit 3 (G6PC3). Click here to read this Defective Medical Devices news article. |
| Tue, 30 Dec 2008 09:00:00 EST New Tool Developed to Predict Colorectal Cancer Risk A new online tool for calculating colorectal cancer risk in men and women age 50 or older was launched today, based on a new risk-assessment model developed by researchers at the National Cancer Institute (NCI), part of the National Institutes of Health. Click here to read this Defective Medical Devices news article. |
| Fri, 19 Dec 2008 15:00:00 EST Twelve Early-Career NIH Researchers Receive Prestigious Award Twelve NIH-supported researchers have been awarded the nation"s highest honor for scientists at the outset of their professional careers. Ten NIH grantees and two intramural NIH scientists were selected by the White House Office of Science and Technology Policy to receive the prestigious 2007 Presidential Early Career Award for Scientists and Engineers (PECASE). Click here to read this Defective Medical Devices news article. |
| Thu, 18 Dec 2008 8:30:00 EST Common Treatment for Chronic Prostatitis Fails to Reduce Symptoms Alfuzosin, a drug commonly prescribed for men with chronic prostatitis, a painful disorder of the prostate and surrounding pelvic area, failed to significantly reduce symptoms in recently diagnosed men who had not been previously treated with this drug, according to a clinical trial sponsored by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), part of the National Institutes of Health (NIH). The study is to be published in the New England Journal of Medicine. Click here to read this Defective Medical Devices news article. |
